Cyxtera Results Presentation Deck
Q3 2022 Results
Core revenue increased by $11.8 million, or 7.3%, year over year to
$172.8 million
Transaction Adjusted EBITDA increased by $0.4 million or 0.8% year
over year, to $58.5 million, principally due to higher revenue partially
offset by higher cost of revenue and SG&A costs
Cyxtera
($ in Millions)
Recurring Revenue
Non-Recurring Revenue
Total Revenue
Cost of Revenue
As a % of Revenue
Gross Profit
% Margin
Total SG&A
As a % of Revenue
Other (1)
EBITDA
% Margin
Transaction Adjustments
Transaction Adjusted EBITDA (2)
% Margin
Rent (net of adjustments)
Transaction Adjusted EBITDAR(3)
% Margin
Capital Expenditures
As a % of Revenue
(1) Q3 22 includes $1.3M in restructuring, impairment, site closures and related cost. Q3 21 includes $4.1M in restructuring, impairment, site closures and related cost
(2) Earnings Before Interest, Taxes, Depreciation, Amortization
(3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent
Q3 '22
$178.1
8.5
$186.6
$100.3
53.8%
$86.2
46.2%
$37.9
20.3%
$1.3
$47.1
25.3%
$11.4
$58.5
31.4%
$15.0
$73.5
39.4%
$38.5
20.6%
Q3 '21
$169.3
7.8
$177.1
$93.5
52.8%
$83.5
47.2%
$29.2
16.5%
$9.3
$45.1
25.4%
$13.0
$58.1
32.8%
$15.7
$73.8
41.7%
$21.4
12.1%
YOY Change
5.2%
9.3%
5.4%
7.3%
96 bps
3.2%
(96 bps)
29.4%
377 bps
ΝΑ
4.6%
(19 bps)
0.8%
(143 bps)
(0.3%)
(226 bps)
79.4%
851 bps
11View entire presentation